September 29, 2020

The Niche

Knoepfler lab stem cell blog

Stem cells for eye disorders webinar: CIRM, ACT, and FDA together

The only biotech with an active hESC-based clinical trial, Advanced Cell Technology (ACT) will have three top leaders including CEO Gary Rabin participating in a CIRM webinar on stem cell-based treatments for eye disorders this Wednesday. Also involved with be Samuel Barone, a medical officer from the FDA.

You don’t want to miss this one!

Register here (required in advance!)

I think CIRM and ACT joining forces on this is a great development.

(Hat tip to David Jensen, who posted on this yesterday)

%d bloggers like this: